Biohaven
(NYSE) BHVN
Biohaven Financials at a Glance
Market Cap
$1.22B
Revenue (TTM)
$0.00
Net Income (TTM)
$738.82M
EPS (TTM)
$-6.96
P/E Ratio
-1.16
Dividend
$0.00
Beta (Volatility)
1.48 (Average)
Dividend
$0.00
Beta (Volatility)
1.48 (Average)
Price
$8.47
Volume
130,468
Open
$8.35
Price
$8.47
Volume
130,468
Open
$8.35
Previous Close
$8.47
Daily Range
$8.23 - $8.60
52-Week Range
$7.48 - $24.21
Dividend
$0.00
Beta (Volatility)
1.48 (Average)
Price
$8.47
Volume
130,468
Open
$8.35
Previous Close
$8.47
Daily Range
$8.23 - $8.60
52-Week Range
$7.48 - $24.21
BHVN News
BHVN: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Biohaven
Industry
Biotechnology
Sector
Health CareEmployees
274
CEO
Vladimir Coric, MD
Website
www.biohaven.comHeadquarters
New Haven, CT 06510, US
BHVN Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-311%
Return on Capital
-2%
Return on Assets
-2%
Earnings Yield
-86.21%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.22B
Shares Outstanding
150.42M
Volume
130.47K
Short Interest
0.00%
Avg. Volume
2.59M
Financials (TTM)
Gross Profit
$4.14M
Operating Income
$745.38M
EBITDA
$727.46M
Operating Cash Flow
$609.44M
Capital Expenditure
$715.00K
Free Cash Flow
$610.15M
Cash & ST Invst.
$319.14M
Total Debt
$278.86M
Biohaven Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$960.00K
N/A
Gross Margin
0.00%
N/A
Market Cap
$1.22B
N/A
Market Cap/Employee
$4.75M
N/A
Employees
256
N/A
Net Income
$145.56M
+22.1%
EBITDA
$142.63M
+23.9%
Quarterly Fundamentals
Net Cash
$40.28M
-91.0%
Accounts Receivable
$0.00
-100.0%
Inventory
$0.00
N/A
Long Term Debt
$278.86M
+750.6%
Short Term Debt
$0.00
-100.0%
Return on Assets
-1.64%
N/A
Return on Invested Capital
-2.22%
N/A
Free Cash Flow
$130.67M
+23.5%
Operating Cash Flow
$130.66M
+23.5%